Patent Assignment
Reel/Frame 058815/0213
Assignment of Assignor's Interest
Recorded: 2022-01-28
Pages: 3
Assignee
AUCTA PHARMACEUTICALS, INC.
675 US ROUTE 1, NORTH BRUNSWICK, NEW JERSEY, 08902
Covered Property
(1)
Powder for oral suspension containing lamotrigine
Application:
16/974,343 →
Publication:
US 2021/0401748
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Sep 20, 2021
From: AZURITY PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057532/0424 →
Assignment of Assignor's Interest
Jan 28, 2022
From: AUCTA PHARMACEUTICALS, INC.
To: SHANGHAI AUCTA PHARMACEUTICALS CO., LTD.
Reel/Frame 058815/0246 →
Assignment of Assignor's Interest
Mar 2, 2022
From: SHANGHAI AUCTA PHARMACEUTICALS CO., LTD.
To: ETON PHARMACEUTICALS, INC.
Reel/Frame 059151/0119 →
Assignment of Assignor's Interest
Mar 2, 2022
From: ETON PHARMACEUTICALS, INC.
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 059151/0129 →
Release of Security Interest
Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →